1997
DOI: 10.1093/mutage/12.3.163
|View full text |Cite
|
Sign up to set email alerts
|

Industrial Genotoxicology Group collaborative trial to investigate cell cycle parameters in human lymphocyte cytogenetics studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0
1

Year Published

1999
1999
2019
2019

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 22 publications
(11 citation statements)
references
References 15 publications
0
10
0
1
Order By: Relevance
“…For many years, human lymphocyte cultures have been used to assess the clastogenic potential of test substances in vitro (Henderson et al, 1997). However, since many drugs are (in)activated after their metabolization, tests in vivo of mutagenicity are recommended for assessing the clastogenic activity of certain compounds whose activity requires metabolic activation; such an approach also provides conditions closer to those found in humans (Legator and Ward Jr., 1991).…”
Section: Discussionmentioning
confidence: 99%
“…For many years, human lymphocyte cultures have been used to assess the clastogenic potential of test substances in vitro (Henderson et al, 1997). However, since many drugs are (in)activated after their metabolization, tests in vivo of mutagenicity are recommended for assessing the clastogenic activity of certain compounds whose activity requires metabolic activation; such an approach also provides conditions closer to those found in humans (Legator and Ward Jr., 1991).…”
Section: Discussionmentioning
confidence: 99%
“…All viabilities were measured by trypan blue exclusion to avoid artefacts due to toxicity (Henderson et al 1997). The cut-off point suggested by Henderson et al (1997) was 70%.…”
Section: Viabilitiesmentioning
confidence: 99%
“…Donors were not taking any form of medication. The measured cell cycle time of the donors estimated in our laboratory falls within the range 13± 2 h [38]. For the main experiment, aliquots of whole blood (0.5 ml) from each donor were added, separately, to sterile disposable centrifuge tubes containing 4.5 ml RPMI-1640 culture medium supplemented with 20% heatinactivated fetal calf serum (Gibco BRL), 100 U/ml Hepes buffer, 2 mM l-glutamine and antibiotics (1% w/v penicillin and 100 M streptomycin).…”
Section: Cells and Culture Conditionsmentioning
confidence: 62%